Jump to content

Gary Nabel

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Ser Amantio di Nicolao (talk | contribs) at 03:52, 10 September 2018 (→‎Selected publications: add authority control, test). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Gary J. Nabel is the Chief Scientific Officer and Senior Vice President at Sanofi. He completed his undergraduate, MD, and PhD studies at Harvard University (1975, 1980, and 1982, respectively). He completed his dissertation research in the laboratory of immunologist Harvey Cantor and then worked as a postdoctoral fellow in the laboratory of David Baltimore at the Whitehead Institute, studying regulation of HIV gene expression by the recently discovered NF-κB, a host transcription factor.[1] He joined the faculty of the University of Michigan in 1987 and was an HHMI investigator until 1999,[2] working on viral vectors in gene therapy and other subjects. He then served as the inaugural director of the Vaccine Research Center at the NIH before moving to his current position of Sanofi in 2012.[3]

Dr. Nabel was elected into the American Society for Clinical Investigation in 1992 and the National Academy of Medicine in 1998.[4]

See also

References

  • Dolgin, Elie (2013-03-06). "Straight talk with Gary Nabel". Nature Medicine. 19 (3): 256–256. doi:10.1038/nm0313-256. ISSN 1078-8956. Retrieved 2016-12-04.
  • Branswell, Helen (2016-03-17). "Sanofi science chief says it's to time 'think big' about Zika". Retrieved 2017-04-03.
  • Gokhale, Ketaki (2016-07-12). "Sanofi Sees Cure for Cancer Woes in Moving West for Acquisitions". Bloomberg. Retrieved 2017-04-03.
  • Advisory board bio page for the EU-funded Advanced Immunization Technologies project

Notes

  1. ^ Vincent Racaniello and American Society for Microbiology staff (2016-11-23). Interview with Gary Nabel (MD, PhD) for 'Principles of Virology' 4th Edition. Retrieved 2016-12-05.
  2. ^ "Gary J. Nabel, former HHMI Investigator" (Text). HHMI.org. Retrieved 2016-12-04.
  3. ^ Cohen, Jon (2012-11-15). "NIH vaccine chief Gary Nabel trades dream job for big pharma". Science. Retrieved 2016-12-04.
  4. ^ "Gary J Nabel, MD, PhD". The American Society for Clinical Investigation. Retrieved 2017-04-04.

Selected publications

See Google Scholar for citation information.